---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-123704"
form_type: "8-K"
ticker: "ELOX"
cik: "0001035354"
company_name: "Eloxx Pharmaceuticals, Inc."
filed_at: "2022-12-01T23:59:59+00:00"
generated_at: "2026-06-21T10:35:08.974151+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Eloxx Pharmaceuticals effects 1-for-40 reverse stock split to regain Nasdaq bid price compliance

## Summary
- Reverse split at 1-for-40 approved by shareholders on Nov 30, 2022; board set ratio same day.
- Effective at 5:00 PM ET on Dec 1, 2022; split-adjusted trading begins Dec 2 under symbol ELOX.
- Goal is to raise per-share price above Nasdaq's minimum $1 bid requirement and maintain listing.
- Fractional shares will be cashed out at closing price on Nov 30; no fractional shares issued.
- Proportionate adjustments made to outstanding equity awards, warrants, and equity plans.

## SEC filing metadata
- accession: 0001104659-22-123704
- form_type: 8-K
- ticker: ELOX
- cik: 0001035354
- company_name: Eloxx Pharmaceuticals, Inc.
- filed_at: 2022-12-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.03, 5.03, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1035354/000110465922123704/0001104659-22-123704-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1035354/000110465922123704/tm2231725d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-123704
- JSON: https://secwatch.observer/filing/0001104659-22-123704.json
- Plain text: https://secwatch.observer/filing/0001104659-22-123704.txt

## Key facts
- Governance Changes
  Eloxx Pharmaceuticals, Inc.: Implemented a 1-for-40 reverse stock split by filing a Certificate of Amendment to the Certificate of Incorporation (effective 2022-12-01).
  - Change: charter amendment
  - Effective: 2022-12-01
  source text: On December 1, 2022, the Company filed with the Secretary of State of the State of Delaware a certificate of amendment (the “ Certificate of Amendment ”) with the Secretary of State of the State of Delaware to amend the Company’s Certificate of Incorporation to effect the Reverse Stock Split. The Reverse Stock Split became effective at 5:00 p.m., Eastern Time, on December 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1035354/000110465922123704/0001104659-22-123704-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.